USC Researchers Adopted New Nanovial Cell Tech
A $2.5 million award supports a study at USC utilizing Partillion Bioscience technology to improve CAR T-cell therapies.
Live Poll
Should government agencies prioritize funding for research into experimental cell-based cancer therapies?